This site is intended for healthcare professionals only
LoginRegister
Sanofi to expand respiratory vaccines pipeline with acquisition of VicebioSanofi to expand respiratory vaccines pipeline with acquisition of Vicebio
Maternal RSV Vaccine Cuts Infant Hospitalizations by 72 Percent: Study FindsMaternal RSV Vaccine Cuts Infant Hospitalizations by 72 Percent: Study Finds
JAPI Releases Dedicated Supplement Addressing Clinical Needs for Adult Vaccination in IndiaJAPI Releases Dedicated Supplement Addressing Clinical Needs for Adult Vaccination in India
Indias landmark Dengue Vaccine trial enrolment to wrap up by October: ICMRIndia's landmark Dengue vaccine trial enrolment to wrap up by October: ICMR
Moderna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID riskModerna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID risk
No connection between COVID, vaccine and heart attacks: Karnataka expert committeeNo connection between COVID, vaccine and heart attacks, Karnataka expert committee finds amid...
Vaccination as a new form of cardiovascular prevention: an ESC Clinical Consensus StatementVaccination as a new form of cardiovascular prevention: an ESC Clinical Consensus Statement
Shingles and RSV Vaccines Linked to Lower Dementia Risk in Older Adults: StudyShingles and RSV Vaccines Linked to Lower Dementia Risk in Older Adults: Study
COVID-19 Vaccine and Heart Attack: Biocon Chief, Karnataka CM get into war of wordsCOVID-19 Vaccine and Heart Attack: Biocon Chief, Karnataka CM get into war of words
Vaccinated COVID-19 Patients with AKI Have Better Outcomes, Less Likely to Require Dialysis: RECOVID StudyVaccinated COVID-19 Patients with AKI Have Better Outcomes, Less Likely to Require Dialysis: RECOVID...
malaria vaccine price reductionBharat Biotech to cut malaria vaccine RTS.S price to under USD 5 for children in endemic countries
CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab TrialGSK application for expanded use of RSV vaccine in adults aged 18-49 accepted in Japan
X